JP6592175B2 - 光安定性の向上した組成物 - Google Patents

光安定性の向上した組成物 Download PDF

Info

Publication number
JP6592175B2
JP6592175B2 JP2018240509A JP2018240509A JP6592175B2 JP 6592175 B2 JP6592175 B2 JP 6592175B2 JP 2018240509 A JP2018240509 A JP 2018240509A JP 2018240509 A JP2018240509 A JP 2018240509A JP 6592175 B2 JP6592175 B2 JP 6592175B2
Authority
JP
Japan
Prior art keywords
solid composition
oral solid
iron oxide
amlodipine
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2018240509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019043964A5 (https=
JP2019043964A (ja
Inventor
落合　康
康 落合
昌史 梅村
昌史 梅村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Priority to JP2018240509A priority Critical patent/JP6592175B2/ja
Publication of JP2019043964A publication Critical patent/JP2019043964A/ja
Publication of JP2019043964A5 publication Critical patent/JP2019043964A5/ja
Application granted granted Critical
Publication of JP6592175B2 publication Critical patent/JP6592175B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018240509A 2018-12-25 2018-12-25 光安定性の向上した組成物 Expired - Lifetime JP6592175B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018240509A JP6592175B2 (ja) 2018-12-25 2018-12-25 光安定性の向上した組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018240509A JP6592175B2 (ja) 2018-12-25 2018-12-25 光安定性の向上した組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017247675A Division JP2018044015A (ja) 2017-12-25 2017-12-25 光安定性の向上した組成物

Publications (3)

Publication Number Publication Date
JP2019043964A JP2019043964A (ja) 2019-03-22
JP2019043964A5 JP2019043964A5 (https=) 2019-09-05
JP6592175B2 true JP6592175B2 (ja) 2019-10-16

Family

ID=65815373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018240509A Expired - Lifetime JP6592175B2 (ja) 2018-12-25 2018-12-25 光安定性の向上した組成物

Country Status (1)

Country Link
JP (1) JP6592175B2 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080095841A1 (en) * 2004-10-06 2008-04-24 Eisai R&D Management Co., Ltd. Pharmaceutical Composition, Method for Producing the Same, and Method for Stabilizing Dihydropyridine Compound in the Pharmaceutical Composition

Also Published As

Publication number Publication date
JP2019043964A (ja) 2019-03-22

Similar Documents

Publication Publication Date Title
JP4214128B2 (ja) 光安定性の向上した組成物
JP5591128B2 (ja) 内核を有する口腔内崩壊錠
JP5296456B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
US10398694B2 (en) Multi-layered tablet containing drug unstable to light
JP2015221826A (ja) イルベサルタンとアムロジピンまたはその塩を含有する医薬組成物
US8426451B2 (en) Oral solid preparation and method of manufacturing the same
JP2011105694A (ja) オロパタジン経口固形組成物
US11116727B2 (en) Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
JP5820951B2 (ja) 光安定性の向上した組成物
JP5689192B2 (ja) 光安定性の向上した組成物
JP4954961B2 (ja) 光安定性の向上した組成物
JP6592175B2 (ja) 光安定性の向上した組成物
JP5689052B2 (ja) 光安定性の向上した組成物
JP2018044015A (ja) 光安定性の向上した組成物
TWI651085B (zh) Ｎ－［５－［２－（３，５－二甲氧基苯基）乙基］－２ｈ－吡唑－３－基］－４－［（３ｒ，５ｓ）－３，５－二甲基哌－１－基］苯甲醯胺之醫藥調配物
JP2017057224A (ja) 光安定性の向上した組成物
JP2016033144A (ja) 光安定性の向上した組成物
JP2015017134A (ja) 光安定性の向上した組成物
JP6601844B2 (ja) 光安定性に優れたミルタザピン含有医薬製剤
KR20080037425A (ko) 광 안정성이 향상된 조성물
JP4575717B2 (ja) アンピロキシカム含有医薬組成物とその安定化方法及びその製造方法
JP2021113237A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
CN101167695A (zh) 光稳定性提高的组合物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190729

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20190729

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20190801

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190822

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190919

R150 Certificate of patent or registration of utility model

Ref document number: 6592175

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term